Evidence map›Paper›PMID 42873826›Full record

ArticlePLoS pathogens2026

Human cytomegalovirus exploits host chromatin remodeler MORC2 to promote the DNA damage response on viral genomes.

Jiseok Jeong, Dongjoon Jeong, Sungwon Lee, Junhyun Park, Hyewon Kim, Kwangseog Ahn

Abstract read
PubMed Publisher
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiseok JeongCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Dongjoon JeongCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Sungwon LeeCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Junhyun ParkCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Hyewon KimCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.
Kwangseog AhnCenter for RNA Research, Institute for Basic Science, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-1015-245X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) harbors a 230-kb double-stranded DNA genome whose replication induces extensive DNA damage during lytic infection. Because HCMV lacks canonical DNA repair machinery, it relies on host DNA damage response (DDR) pathways. However, the mechanisms that govern the preferential recruitment and function of host DDR proteins on viral genomes remain poorly understood. Here, we show that HCMV co-opts the host chromatin remodeler MORC Family CW-type zinc finger 2 (MORC2) to promote DDR activation on viral genomes. HCMV infection induces MORC2 expression, which is important for efficient viral DNA replication and progeny virus production. We found that MORC2 redistributes to viral replication compartments (vRCs) in HCMV-infected cells and enhances viral chromatin accessibility in an ATPase-dependent manner, thereby facilitating γH2AX accumulation and the recruitment of DNA repair factors to vRCs. Furthermore, we found that HCMV UL112-113-mediated phase separation facilitates MORC2 recruitment to vRCs, promoting efficient DDR signaling on viral genomes. Together, these findings provide a mechanistic framework for how DNA viruses alleviate replication stress by hijacking host chromatin remodelers.

Indexed as

Chromatin Assembly and DisassemblyCytomegalovirusCytomegalovirus InfectionsDNA DamageGenome, ViralTranscription FactorsDNA RepairDNA ReplicationDNA, ViralHost-Pathogen InteractionsHumansVirus ReplicationDNA, ViralMORC2 protein, humanTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.